Zhang Haisheng is the founder of Signet Therapeutics. Signet Therapeutics has raised $31M in total funding. Latest round: Seed.
Haisheng Zhang is the Co-Founder and President of Signet Therapeutics, a clinical-stage biotech company developing targeted cancer therapies. He also holds a position as a Research Fellow at Dana-Farber Cancer Institute and is Co-President at MIT-CHIEF. Zhang founded Signet Therapeutics in 2020, focusing on first-in-class oncology treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide